Brain zap plus exercise may fight frailty in seniors
NCT ID NCT07346989
First seen Jun 25, 2026 · Last updated Jul 07, 2026 · Updated 3 times
Summary
This study tests whether a non-invasive brain stimulation technique called rTMS, combined with a therapeutic exercise program, can improve physical function and quality of life in prefrail older adults aged 65-90. Researchers will measure changes in frailty status, walking speed, and brain plasticity markers. The goal is to find a safe, effective way to prevent decline and help seniors maintain independence.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- non-invasive brain stimulation (rTMS) plus therapeutic exercise
- What this could lead to
- If it works, this could point toward a safe, drug-free way to help older adults stay stronger and more independent.
- What could go wrong
- This is an early-stage study with only 120 participants, so results may not apply to everyone. The effect may be small or no better than exercise alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Jul 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 65 -90 years old * Meet 1-2 frailty criteria, according to Fried's Criteria. * Ability to understand instructions (Mini-Mental State Examination \>23 points). * Signing of the informed consent. Exclusion Criteria: * History of stroke within the past 6 months or hospital admission for any reason within the past 3 months. * Alterations of the central or peripheral nervous system * Alterations of the vestibular system * Concomitant diseases * Have a neurological pathology, cardiovascular musculoskeletal that contraindicates physical activity * Epilepsy or history, medications that lower the seizure threshold * Cardiac pacemaker, endocranial and hearing implants * History of severe headaches * Uncontrolled intracranial or arterial hypertension * Heart and/or respiratory failure * Implanted medication pump * Skin lesions (psoriasis, eczema) * Serious head surgeries * Completing less than 80% of training sessions
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prefrail elderly are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Valencia
RECRUITINGValencia, Valencia, 46010, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.